It's a Wednesday afternoon, and things are hopping at the McGuire Translational Research Facility.
In one of the 30 offices lining the south side of the four-story
building, a faculty member in the Division of Infectious Diseases and
International Medicine is tapping intently at a keyboard. Just down the
hall, through doors that open to a long, day-lit laboratory, a student
pipettes liquid into a rack full of tubes, preparing to grow plasmids
as part of a study on developing gene therapies for brain cancer. At a
table looking out over the four-story atrium, three graduate
students—perhaps from the Stem Cell Institute or the orphan drug
program—eat late lunches from plastic containers. Upstairs and down,
dozens of others are working on solutions to a spectrum of health
problems: TB, HIV, malaria, Parkinson's, spinal cord injury.